Chemoinformaics analysis of Regholarrhenine D
| Molecular Weight | 358.57 | nRot | 1 |
| Heavy Atom Molecular Weight | 320.266 | nRig | 24 |
| Exact Molecular Weight | 358.298 | nRing | 5 |
| Solubility: LogS | -3.472 | nHRing | 1 |
| Solubility: LogP | 4.219 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 66.7501 |
| nHD | 1 | BPOL | 40.4019 |
| QED | 0.696 |
| Synth | 5.157 |
| Natural Product Likeliness | 2.157 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.017 |
| CACO-2 | -4.83 |
| MDCK | 0.00000479 |
| BBB | 0.886 |
| PPB | 0.663859 |
| VDSS | 1.37 |
| FU | 0.306514 |
| CYP1A2-inh | 0.035 |
| CYP1A2-sub | 0.511 |
| CYP2c19-inh | 0.031 |
| CYP2c19-sub | 0.987 |
| CYP2c9-inh | 0.053 |
| CYP2c9-sub | 0.139 |
| CYP2d6-inh | 0.942 |
| CYP2d6-sub | 0.925 |
| CYP3a4-inh | 0.102 |
| CYP3a4-sub | 0.869 |
| CL | 18.253 |
| T12 | 0.032 |
| hERG | 0.131 |
| Ames | 0.02 |
| ROA | 0.115 |
| SkinSen | 0.015 |
| Carcinogencity | 0.414 |
| EI | 0.008 |
| Respiratory | 0.981 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.710103 |